Allan Dillner

995 citations
14 papers · 865 indexed · h-index 11

Allan Dillner

14 papers receiving 855 citations

Peers

Allan Dillner
Comparison fields: 5 of 81
  • Immunology 241
  • Virology 51
  • Cancer Research 148
  • Epidemiology 246
  • Oncology 164
Replace Sam K. P. Kung with:
Sam K. P. Kung Canada
Simon Yu United States
Francis M. Sverdrup United States
Patricio Gariglio Mexico
Wen-Qi Cai China
David M. Calderhead United States
Rama Mohan Surabhi United States
L. Murphy United Kingdom
Takis Athanasopoulos United Kingdom
Mohammed Oukka United States
Allan Dillner relative to Sam K. P. Kung Canada Sam K. P. Kung's profile →
Citations per field
00.5×1.5×1.8×
Sam K. P. Kung · 1×
Citations per year

Countries citing papers authored by Allan Dillner

Since Specialization
Citations

This map shows the geographic impact of Allan Dillner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan Dillner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan Dillner more than expected).

Fields of papers citing papers by Allan Dillner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan Dillner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan Dillner. The network helps show where Allan Dillner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Allan Dillner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Allan Dillner Line = papers co-authored together Allan Dillner links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 200414
2 2003211
3 20031
4 20031
5 1998161
6 199844
7 19983
8
An HSV-1 containing the rat beta-glucuronidase cDNA inserted within the LAT gene is less efficient than the parental strain at establishing a transcriptionally active state during latency in neurons.
199517
9 1995209
10 199428
11 199335
12 199322
13 199237
14 199182

About Allan Dillner

Allan Dillner is a scholar working on Cancer Research, Epidemiology and Immunology, having authored 14 papers that have together received 865 indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (6 papers), NF-κB Signaling Pathways (4 papers), Immune Response and Inflammation (3 papers), Cytomegalovirus and herpesvirus research (3 papers), Virus-based gene therapy research (2 papers), melanin and skin pigmentation (2 papers), TGF-β signaling in diseases (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Immunology (241 citations), Virology (51 citations) and Cancer Research (148 citations). Allan Dillner has collaborated with scholars based in United States and Russia. Frequent co-authors include Peter F. Johnson, M Baer, Simon C. Williams, Yi Tang, Lopa Mishra, Varalakshmi Katuri, Mark Baer, Richard C. Schwartz, Bibhuti Mishra and Tibor Vályi-Nagy. Their work appears in journals such as Virology, Journal of Virology, Gastroenterology, Blood and Microbial Pathogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026